N-Acetyl Selank Amidate
Cognitive & neuro Research only Animal studies
Also called NA-Selank Amidate
Selank with the same end-capping treatment: acetylated at one end, amidated at the other, to resist enzymatic breakdown. The underlying seven-amino-acid sequence and its anti-anxiety activity are unchanged.
Why people take it
What studies report
- Shares the core sequence of Selank, which reduced anxiety without sedation in Russian trials
- Terminal caps slow enzymatic degradation in lab assays
In practice Unapproved use
- Preferred by users who find plain Selank too short-acting
Reported real-world use, not evidence and not a recommendation.
Worth knowing: As with the capped Semax, nearly all the supporting evidence belongs to the parent peptide rather than this modified version.
Status: Research compound. Not approved.
- Route
- Intranasal spray
- Sequence
- Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2
- Available as
- 20 mg
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.